413 related articles for article (PubMed ID: 30936689)
1. Cost-effectiveness of the COPD Patient Management European Trial home-based disease management program.
Bourbeau J; Granados D; Roze S; Durand-Zaleski I; Casan P; Köhler D; Tognella S; Viejo JL; Dal Negro RW; Kessler R
Int J Chron Obstruct Pulmon Dis; 2019; 14():645-657. PubMed ID: 30936689
[TBL] [Abstract][Full Text] [Related]
2. Optimizing chronic disease management mega-analysis: economic evaluation.
Path-Theta Collaboration
Ont Health Technol Assess Ser; 2013; 13(13):1-148. PubMed ID: 24228076
[TBL] [Abstract][Full Text] [Related]
3. Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain.
Tunis SL; Willis WD; Foos V
Curr Med Res Opin; 2010 Jan; 26(1):163-75. PubMed ID: 19919377
[TBL] [Abstract][Full Text] [Related]
4. Long-term cost-effectiveness of home versus clinic-based management of chronic heart failure: the WHICH? study.
Maru S; Byrnes JM; Carrington MJ; Stewart S; Scuffham PA
J Med Econ; 2017 Apr; 20(4):318-327. PubMed ID: 27841726
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis for a tele-based health coaching program for chronic disease in primary care.
Oksman E; Linna M; Hörhammer I; Lammintakanen J; Talja M
BMC Health Serv Res; 2017 Feb; 17(1):138. PubMed ID: 28202032
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of home versus clinic-based management of chronic heart failure: Extended follow-up of a pragmatic, multicentre randomized trial cohort - The WHICH? study (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care).
Maru S; Byrnes J; Carrington MJ; Chan YK; Thompson DR; Stewart S; Scuffham PA;
Int J Cardiol; 2015 Dec; 201():368-75. PubMed ID: 26310979
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of physical activity in the management of COPD patients in the UK.
Ramos M; Lamotte M; Gerlier L; Svangren P; Miquel-Cases A; Haughney J
Int J Chron Obstruct Pulmon Dis; 2019; 14():227-239. PubMed ID: 30697043
[TBL] [Abstract][Full Text] [Related]
8. An international randomized study of a home-based self-management program for severe COPD: the COMET.
Bourbeau J; Casan P; Tognella S; Haidl P; Texereau JB; Kessler R
Int J Chron Obstruct Pulmon Dis; 2016; 11():1447-51. PubMed ID: 27418817
[TBL] [Abstract][Full Text] [Related]
9. Cost-utility analysis of a preventive home visit program for older adults in Germany.
Brettschneider C; Luck T; Fleischer S; Roling G; Beutner K; Luppa M; Behrens J; Riedel-Heller SG; König HH
BMC Health Serv Res; 2015 Apr; 15():141. PubMed ID: 25884452
[TBL] [Abstract][Full Text] [Related]
10. The cost effectiveness of REACH-HF and home-based cardiac rehabilitation compared with the usual medical care for heart failure with reduced ejection fraction: A decision model-based analysis.
Taylor RS; Sadler S; Dalal HM; Warren FC; Jolly K; Davis RC; Doherty P; Miles J; Greaves C; Wingham J; Hillsdon M; Abraham C; Frost J; Singh S; Hayward C; Eyre V; Paul K; Lang CC; Smith K
Eur J Prev Cardiol; 2019 Aug; 26(12):1252-1261. PubMed ID: 30884975
[TBL] [Abstract][Full Text] [Related]
11. Economic evaluation of a disease management program for chronic obstructive pulmonary disease.
Dewan NA; Rice KL; Caldwell M; Hilleman DE
COPD; 2011 Jun; 8(3):153-9. PubMed ID: 21513435
[TBL] [Abstract][Full Text] [Related]
12. Within trial cost-utility analysis of disease management program for patients hospitalized with atrial fibrillation: results from the SAFETY trial.
Byrnes J; Ball J; Gao L; Kai Chan Y; Kularatna S; Stewart S; Scuffham PA
J Med Econ; 2019 Sep; 22(9):945-952. PubMed ID: 31190590
[No Abstract] [Full Text] [Related]
13. [Roflumilast in combination with long-acting bronchodilators in the management of patients with severe and very severe COPD. A cost-effectiveness analysis for Germany].
Nowak D; Ehlken B; Kotchie R; Wecht S; Magnussen H
Dtsch Med Wochenschr; 2013 Jan; 138(4):119-25. PubMed ID: 23322425
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of telehealthcare to patients with chronic obstructive pulmonary disease: results from the Danish 'TeleCare North' cluster-randomised trial.
Witt Udsen F; Lilholt PH; Hejlesen O; Ehlers L
BMJ Open; 2017 May; 7(5):e014616. PubMed ID: 28515193
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of Pulmonary Rehabilitation Among US Adults With Chronic Obstructive Pulmonary Disease.
Mosher CL; Nanna MG; Jawitz OK; Raman V; Farrow NE; Aleem S; Casaburi R; MacIntyre NR; Palmer SM; Myers ER
JAMA Netw Open; 2022 Jun; 5(6):e2218189. PubMed ID: 35731514
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of early assisted discharge for COPD exacerbations in The Netherlands.
Goossens LM; Utens CM; Smeenk FW; van Schayck OC; van Vliet M; van Litsenburg W; Braken MW; Rutten-van Mölken MP
Value Health; 2013 Jun; 16(4):517-28. PubMed ID: 23796285
[TBL] [Abstract][Full Text] [Related]
17. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
18. Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone in Patients with COPD-A Cost-Effectiveness Analysis in the Czech Republic.
Skoupa J; Kasak V; Klimes J; Valena T
Value Health Reg Issues; 2018 Sep; 16():112-118. PubMed ID: 30539739
[TBL] [Abstract][Full Text] [Related]
19. Estimating the cost-effectiveness of fluticasone propionate for treating chronic obstructive pulmonary disease in the presence of missing data.
Briggs AH; Lozano-Ortega G; Spencer S; Bale G; Spencer MD; Burge PS
Value Health; 2006; 9(4):227-35. PubMed ID: 16903992
[TBL] [Abstract][Full Text] [Related]
20. Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease.
Spencer M; Briggs AH; Grossman RF; Rance L
Pharmacoeconomics; 2005; 23(6):619-37. PubMed ID: 15960557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
